Fresenius SE & Co. KGaA (FRA:FRE) Given a €85.00 Price Target at S&P Global

Fresenius SE & Co. KGaA (FRA:FRE) has been assigned a €85.00 ($100.00) price objective by stock analysts at S&P Global in a report released on Monday, November 6th. The firm currently has a “buy” rating on the stock. S&P Global’s price target indicates a potential upside of 39.89% from the company’s current price.

Several other brokerages have also recently issued reports on FRE. Bank of America Corporation set a €75.00 ($88.24) target price on Fresenius SE & Co. KGaA and gave the company a “neutral” rating in a report on Monday, November 6th. Goldman Sachs Group Inc set a €78.00 ($91.76) target price on Fresenius SE & Co. KGaA and gave the company a “neutral” rating in a report on Monday, November 6th. Deutsche Bank AG set a €84.00 ($98.82) price target on Fresenius SE & Co. KGaA and gave the stock a “buy” rating in a report on Friday, November 3rd. Oddo Bhf set a €82.00 ($96.47) price target on Fresenius SE & Co. KGaA and gave the stock a “buy” rating in a report on Friday, November 3rd. Finally, Kepler Capital Markets set a €77.00 ($90.59) price target on Fresenius SE & Co. KGaA and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. Seven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of €80.41 ($94.60).

Shares of Fresenius SE & Co. KGaA (FRE) traded down €0.68 ($0.80) during trading hours on Monday, reaching €60.76 ($71.48). The company’s stock had a trading volume of 2,277,048 shares. Fresenius SE & Co. KGaA has a 12 month low of €61.16 ($71.95) and a 12 month high of €80.00 ($94.12).

TRADEMARK VIOLATION NOTICE: This news story was published by BBNS and is the sole property of of BBNS. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://baseballnewssource.com/markets/fresenius-se-85-00-price-target-at-sp-global/1761624.html.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co. KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.